Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Agios Pharmaceuticals 88 SIDNEY STREET CAMBRIDGE MA 02139 USA

www.agios.com Employees: 540 P: 617-649-8600 F: 617-344-0070

Sector:

Medical

Description:

Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.

Key Statistics

Overview:

Market Capitalization, $K 2,058,923
Enterprise Value, $K 1,969,793
Shares Outstanding, K 58,592
Float, K 56,073
% Float 95.70%
Short Interest, K 6,606
Short Float 11.27%
Days to Cover 6.36
Short Volume Ratio 0.50
% of Insider Shareholders 4.30%

Financials:

Annual Sales, $ 54,030 K
Annual Net Income, $ -412,780 K
Last Quarter Sales, $ 19,970 K
Last Quarter Net Income, $ -108,040 K
EBIT, $ -472,140 K
EBITDA, $ -474,160 K

Growth:

1-Year Return 27.04%
3-Year Return 54.94%
5-Year Return -35.79%
5-Year Revenue Growth -73.41%
5-Year Earnings Growth -50.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.85 on 02/12/26
Next Earnings Date 04/29/26 [BMO]
Earnings Per Share ttm -7.11
EPS Growth vs. Prev Qtr -3.93%
EPS Growth vs. Prev Year -6.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AGIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.07%
Return-on-Assets % -28.92%
Profit Margin % -763.98%
Debt/Equity 0.00
Price/Sales 37.87
Price/Cash Flow N/A
Price/Book 1.71
Book Value/Share 20.46
Interest Coverage -1.30
60-Month Beta 0.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.